Amylyx Pharmaceuticals, Inc.

Amylyx Pharmaceuticals, Inc.verified

AMLX

Price:

$1.825

Market Cap:

$124.11M

Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of amyotrophic lateral sclerosis. It is also developing AMX0035 for other neurodegenerative diseases. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.[Read more]

Industry

Biotechnology

IPO Date

2022-01-07

Stock Exchange

NASDAQ

Ticker

AMLX

The Enterprise Value as of June 2024 (TTM) for Amylyx Pharmaceuticals, Inc. (AMLX) is -42747506.00

According to Amylyx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -42747506.00. This represents a change of -105.42% compared to the average of 788.76M of the last 4 quarters.

Amylyx Pharmaceuticals, Inc. (AMLX) Historical Enterprise Value (quarterly & annually)

How has AMLX Enterprise Value performed in the past?

The mean historical Enterprise Value of Amylyx Pharmaceuticals, Inc. over the last ten years is 1.25B. The current -42747506.00 Enterprise Value has changed -441.35% with respect to the historical average. Over the past ten years (40 quarters), AMLX's Enterprise Value was at its highest in in the December 2022 quarter at 2.36B. The Enterprise Value was at its lowest in in the March 2021 quarter at 0.

Quarterly (TTM)
Annual

Average

1.25B

Median

1.01B

Minimum

823.73M

Maximum

2.40B

Amylyx Pharmaceuticals, Inc. (AMLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Amylyx Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 141.24%

Maximum Annual Enterprise Value = 2.40B

Minimum Annual Increase = -65.70%

Minimum Annual Enterprise Value = 823.73M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023823.73M-65.70%
20222.40B141.24%
2021995.41M-1.34%
20201.01B-2.26%

Amylyx Pharmaceuticals, Inc. (AMLX) Average Enterprise Value

How has AMLX Enterprise Value performed in the past?

The current Enterprise Value of Amylyx Pharmaceuticals, Inc. (AMLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.41B

5-year avg

1.25B

10-year avg

1.25B

Amylyx Pharmaceuticals, Inc. (AMLX) Enterprise Value vs. Peers

How is AMLX’s Enterprise Value compared to its peers?

Amylyx Pharmaceuticals, Inc.’s Enterprise Value is less than Terns Pharmaceuticals, Inc. (435.28M), less than Acumen Pharmaceuticals, Inc. (120.33M), less than Inozyme Pharma, Inc. (303.75M), less than X4 Pharmaceuticals, Inc. (164.04M), less than Day One Biopharmaceuticals, Inc. (951.18M), less than Mereo BioPharma Group plc (503.75M), less than PDS Biotechnology Corporation (68.25M), less than HOOKIPA Pharma Inc. (-23428357.00),

Build a custom stock screener for Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Amylyx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Amylyx Pharmaceuticals, Inc. (AMLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Amylyx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Amylyx Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the 3-year average Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX)?

What is the 5-year average Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX)?

How does the current Enterprise Value for Amylyx Pharmaceuticals, Inc. (AMLX) compare to its historical average?